1. Home
  2. FLO vs VCEL Comparison

FLO vs VCEL Comparison

Compare FLO & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flowers Foods Inc.

FLO

Flowers Foods Inc.

HOLD

Current Price

$8.54

Market Cap

1.9B

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$35.06

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLO
VCEL
Founded
1919
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.7B
IPO Year
2000
1996

Fundamental Metrics

Financial Performance
Metric
FLO
VCEL
Price
$8.54
$35.06
Analyst Decision
Hold
Strong Buy
Analyst Count
5
5
Target Price
$11.20
$58.50
AVG Volume (30 Days)
4.3M
707.3K
Earning Date
05-15-2026
05-07-2026
Dividend Yield
11.98%
N/A
EPS Growth
N/A
60.00
EPS
0.40
0.32
Revenue
$5,256,479,000.00
$276,259,000.00
Revenue This Year
N/A
$19.10
Revenue Next Year
$0.65
$17.95
P/E Ratio
$20.66
$109.84
Revenue Growth
3.00
16.45
52 Week Low
$7.86
$28.95
52 Week High
$18.53
$45.97

Technical Indicators

Market Signals
Indicator
FLO
VCEL
Relative Strength Index (RSI) 48.99 58.72
Support Level N/A $34.26
Resistance Level $8.62 $38.48
Average True Range (ATR) 0.30 1.37
MACD 0.09 0.46
Stochastic Oscillator 87.58 94.67

Price Performance

Historical Comparison
FLO
VCEL

About FLO Flowers Foods Inc.

Flowers Foods Inc operates as a producer and marketer of packaged bakery foods in the United States. Its principal products include breads, buns, rolls, snack items (bars, cakes, cookies, and crackers), bagels, English muffins, tortillas, and baking mixes. These products are sold under the brand names Nature's Own, Dave's Killer Bread (DKB), Canyon Bakehouse, Simple Mills, Wonder, and Tastykake. The company derives the majority of its revenue from the sales of its bakery products.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: